Download Files:
Products Details
Product Description
– PSMA-IN-3 (compound 17) is a novel high-affinity PSMA inhibitor with an IC50 value of 13 nM. PSMA-IN-3 is suitable for developing an 18F-labeled radioligand for PET imaging of PSMA in prostate cancer[1].
Web ID
– HY-149869
Shipping
– Room temperature
Molecular Formula
– C43H50FN7O15
References
– [1]Gade NR, et al. N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors. ACS Med Chem Lett. 2023 Jun 9;14(7):943-948.
Molecular Weight
– 923.89
SMILES
– FC1=CC=C(C=C1)/C=N/OCC(NCC(N[C@H](C(O)=O)CC2=CC=C(C=C2)OCC(N[C@H](C(NCCCC[C@H](NC(N[C@H](C(O)=O)CCC(O)=O)=O)C(O)=O)=O)CC3=CC=CC=C3)=O)=O)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– PSMA
Pathway
– Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
